SK285109B6 - Termodynamicky stabilná modifikácia I ramatrobanu, spôsob jej výroby, jej použitie a farmaceutický prostriedok s jej obsahom - Google Patents

Termodynamicky stabilná modifikácia I ramatrobanu, spôsob jej výroby, jej použitie a farmaceutický prostriedok s jej obsahom Download PDF

Info

Publication number
SK285109B6
SK285109B6 SK975-2000A SK9752000A SK285109B6 SK 285109 B6 SK285109 B6 SK 285109B6 SK 9752000 A SK9752000 A SK 9752000A SK 285109 B6 SK285109 B6 SK 285109B6
Authority
SK
Slovakia
Prior art keywords
ramatroban
modification
thermodynamically stable
stable modification
maximum
Prior art date
Application number
SK975-2000A
Other languages
English (en)
Slovak (sk)
Other versions
SK9752000A3 (en
Inventor
Alfons Grunenberg
Karl-Heinz Wahl
Klaus-Peter Voges
Original Assignee
Bayer Yakuhin, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Yakuhin, Ltd. filed Critical Bayer Yakuhin, Ltd.
Publication of SK9752000A3 publication Critical patent/SK9752000A3/sk
Publication of SK285109B6 publication Critical patent/SK285109B6/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/82Carbazoles; Hydrogenated carbazoles
    • C07D209/88Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
SK975-2000A 1997-12-24 1998-12-24 Termodynamicky stabilná modifikácia I ramatrobanu, spôsob jej výroby, jej použitie a farmaceutický prostriedok s jej obsahom SK285109B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19757983A DE19757983A1 (de) 1997-12-24 1997-12-24 Thermodynamisch stabile Form von (r)-3[[(4-Fluorophenyl)sulfonyl]amino]-1,2,3,4-tetrahydro-9H-carbazol-0-propansäure (Ramatroban)
PCT/JP1998/005844 WO1999033803A1 (en) 1997-12-24 1998-12-24 Thermodynamically stable form of (r)-3-[ [(4-fluorophenyl) sulphonyl]amino] -1,2,3,4- tetrahydro -9h-carbazole -9-propanoic acid (ramatroban)

Publications (2)

Publication Number Publication Date
SK9752000A3 SK9752000A3 (en) 2001-02-12
SK285109B6 true SK285109B6 (sk) 2006-06-01

Family

ID=7853457

Family Applications (1)

Application Number Title Priority Date Filing Date
SK975-2000A SK285109B6 (sk) 1997-12-24 1998-12-24 Termodynamicky stabilná modifikácia I ramatrobanu, spôsob jej výroby, jej použitie a farmaceutický prostriedok s jej obsahom

Country Status (37)

Country Link
US (1) US6362214B1 (ru)
EP (1) EP1051398B1 (ru)
JP (2) JP3817668B2 (ru)
KR (1) KR100586350B1 (ru)
CN (1) CN1140510C (ru)
AR (1) AR013803A1 (ru)
AT (1) ATE263152T1 (ru)
AU (1) AU744242B2 (ru)
BG (1) BG65024B1 (ru)
BR (1) BR9814496A (ru)
CA (1) CA2313230A1 (ru)
CO (1) CO4970800A1 (ru)
DE (2) DE19757983A1 (ru)
DK (1) DK1051398T3 (ru)
ES (1) ES2218874T3 (ru)
GT (1) GT199800198A (ru)
HK (1) HK1034517A1 (ru)
HN (1) HN1998000186A (ru)
HU (1) HUP0004432A3 (ru)
ID (1) ID25446A (ru)
IL (1) IL136278A (ru)
IN (1) IN192932B (ru)
MY (1) MY116312A (ru)
NO (1) NO316618B1 (ru)
NZ (1) NZ504741A (ru)
PE (1) PE20000115A1 (ru)
PL (1) PL341359A1 (ru)
PT (1) PT1051398E (ru)
RU (1) RU2220137C2 (ru)
SI (1) SI1051398T1 (ru)
SK (1) SK285109B6 (ru)
TR (1) TR200001936T2 (ru)
TW (1) TW552258B (ru)
UA (1) UA66832C2 (ru)
UY (2) UY25324A1 (ru)
WO (1) WO1999033803A1 (ru)
ZA (1) ZA9811817B (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007336077A1 (en) * 2006-12-20 2008-06-26 Cardoz Ab New combination for use in the treatment of inflammatory disorders
WO2008087371A1 (en) * 2007-01-16 2008-07-24 Cardoz Ab New combination for use in the treatment of inflammatory disorders
WO2009007674A2 (en) * 2007-07-11 2009-01-15 Cardoz Ab Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and ramatroban or seratrodast
CN101434571B (zh) * 2007-11-13 2012-05-30 杭州容立医药科技有限公司 环烷并[1,2-b]吲哚磺酰胺、其异构体或其盐的合成方法
WO2011115069A1 (ja) * 2010-03-19 2011-09-22 第一三共株式会社 結晶の網羅的探索
CN103054857A (zh) * 2012-12-30 2013-04-24 北京阜康仁生物制药科技有限公司 一种以雷马曲班为活性成分的固体制剂
EP4420734A2 (en) 2015-02-13 2024-08-28 Institut National de la Santé et de la Recherche Médicale Ptgdr-1 and/or ptgdr-2 antagonists for preventing and/or treating systemic lupus erythematosus

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3631824A1 (de) 1986-02-21 1988-03-31 Bayer Ag Cycloalkano(1.2-b)indol-sulfonamide
CN1015711B (zh) 1986-02-21 1992-03-04 拜尔公司 制备环烷并[1,2-b]吲哚-磺酰胺类化合物的方法
DE19506739A1 (de) * 1995-02-27 1996-08-29 Bayer Ag [3-Amino]-tetrahydrocarbazol-propansäureester

Also Published As

Publication number Publication date
KR20010033529A (ko) 2001-04-25
US6362214B1 (en) 2002-03-26
JP2001527067A (ja) 2001-12-25
BG65024B1 (bg) 2006-12-29
GT199800198A (es) 1998-12-15
SK9752000A3 (en) 2001-02-12
AU1687499A (en) 1999-07-19
KR100586350B1 (ko) 2006-06-07
BR9814496A (pt) 2000-10-10
PL341359A1 (en) 2001-04-09
CA2313230A1 (en) 1999-07-08
IL136278A (en) 2005-03-20
UY25324A1 (es) 2000-12-29
AR013803A1 (es) 2001-01-10
NO20003217D0 (no) 2000-06-21
UA66832C2 (ru) 2004-06-15
ZA9811817B (en) 1999-06-29
BG104554A (en) 2001-05-31
HUP0004432A3 (en) 2002-10-28
WO1999033803A1 (en) 1999-07-08
ID25446A (id) 2000-10-05
SI1051398T1 (en) 2004-08-31
DE69822882D1 (en) 2004-05-06
EP1051398A1 (en) 2000-11-15
DE69822882T2 (de) 2005-02-03
HK1034517A1 (en) 2001-10-26
EP1051398B1 (en) 2004-03-31
TR200001936T2 (tr) 2001-01-22
NO20003217L (no) 2000-06-21
CN1140510C (zh) 2004-03-03
AU744242B2 (en) 2002-02-21
IL136278A0 (en) 2001-05-20
JP3817668B2 (ja) 2006-09-06
RU2220137C2 (ru) 2003-12-27
PE20000115A1 (es) 2000-03-26
DK1051398T3 (da) 2004-07-19
DE19757983A1 (de) 1999-07-01
HN1998000186A (es) 1999-11-03
MY116312A (en) 2003-12-31
TW552258B (en) 2003-09-11
JP4411269B2 (ja) 2010-02-10
NZ504741A (en) 2002-10-25
CO4970800A1 (es) 2000-11-07
PT1051398E (pt) 2004-07-30
JP2006151977A (ja) 2006-06-15
UY25575A1 (es) 1999-11-17
CN1282320A (zh) 2001-01-31
HUP0004432A2 (hu) 2001-06-28
ES2218874T3 (es) 2004-11-16
NO316618B1 (no) 2004-03-08
IN192932B (ru) 2004-06-12
ATE263152T1 (de) 2004-04-15

Similar Documents

Publication Publication Date Title
HU227625B1 (en) Modifications of 2-amino-4-(4-fluorobenzylamino)-1-ethoxycarbonyl-aminobenzene and processes for preparing them
KR100744360B1 (ko) 5-[4-[2-(n-메틸-n-(2-피리딜)아미노)에톡시]벤질]티아졸리딘-2,4-디온 말레산염의 다형체
JP4411269B2 (ja) (r)−3−[[(4−フルオロフェニル)スルホニル]アミノ]−1,2,3,4−テトラヒドロ−9h−カルバゾール−9−プロパン酸(ラマトロバン)の熱力学的に安定な形態の結晶の製造方法
US6953854B2 (en) Process for preparing crystalline Form I of cabergoline
EP1468997A2 (en) Polymorphous forms of rosiglitazone maleate
JP4657393B2 (ja) ドキサゾシン・メシレートの新規な形態iii
JPH06192228A (ja) 結晶性(r)−(−)−2−シクロヘプチル−n−メチルスルフオニル−[4−(2−キノリニルメトキシ)−フエニル]−アセトアミド
US6492391B1 (en) Crystal modification d of 8-cyano-1-cyclopropyl-7-(1s, 6s- 2,8-diazabicyclo-[4.3.0]nonan-8-yl)-6-fluoro-1,4- dihydro-4-oxo-3-quinolinecarboxylic acid
US10577340B1 (en) Beraprost-314d crystals and methods for preparation thereof
MXPA00005858A (en) Thermodynamically stable form of (r)-3-[ [(4-fluorophenyl) sulphonyl]amino]-1,2,3,4- tetrahydro -9h-carbazole -9-propanoic acid (ramatroban)
CZ20002325A3 (cs) Termodynamicky stabilní modifikace I ramatrobanu, způsob její výroby a její použití
WO2001007404A1 (de) Kristallmodifikation iii von n-(4-(5-dimethylamino-naphthalin-1-sulfonylamino)-phenyl)-3-hydroxy-2,2-dimethyl-propionamid
EP1713769B1 (en) Amorphous tamsulosin hydrochloride
US20110184067A1 (en) O-desmethylvenlafaxine succinate polymorph & process for preparing thereof
EP1768969B1 (en) Crystalline mycophenolate sodium
EP2029556B1 (en) Salts and crystal modifications thereof